Search Results for “” – Page 17 – OSLM

OSLM

Outcome Studies
in Laboratory Medicine

guest

👤

Learn more about this platform

Categories:Economics

181 Publications found

Cost-effectiveness of non-invasive methods for assessment and monitoring of liver fibrosis and cirrhosis in patients with chronic liver disease: systematic review and economic evaluation.

b

Health technology assessment (Winchester, England)

January 1, 2015

p Liver Disease

c Economics Review
Cost effectiveness analysis of pharmacokinetically-guided 5-fluorouracil in FOLFOX chemotherapy for metastatic colorectal cancer.

b

Clinical colorectal cancer

December 1, 2014

p Therapeutic drug monitoring

c Economics Model
Modelling the potential population impact and cost-effectiveness of self-testing for HIV: evaluation of data requirements.

b

AIDS and behavior

July 1, 2014

p HIV POCT

c Economics Model
Individualised therapy is more cost-effective than dose intensification in patients with Crohn’s disease who lose response to anti-TNF treatment: a randomised, controlled trial.

b

Gut

June 1, 2014

p Therapeutic drug monitoring

c Clinical outcomes Economics RCT
Epidermal growth factor receptor tyrosine kinase (EGFR-TK) mutation testing in adults with locally advanced or metastatic non-small cell lung cancer: a systematic review and cost-effectiveness analysis.

b

Health technology assessment (Winchester, England)

May 1, 2014

p Cancer

c Economics Review
A comparison of individualized treatment guided by VeriStrat with standard of care treatment strategies in patients receiving second-line treatment for advanced non-small cell lung cancer: A cost-utility analysis.

b

Lung cancer (Amsterdam, Netherlands)

December 1, 2013

p Cancer

c Clinical outcomes Economics Model
Integrating rapid pathogen identification and antimicrobial stewardship significantly decreases hospital costs.

b

Archives of pathology & laboratory medicine

September 1, 2013

p MALDI-TOF MS For Microorganism Identification

c Clinical outcomes Economics Observational Operational efficiencies
Cost and resource implications with serum angiogenic factor estimation in the triage of pre-eclampsia.

b

BJOG : an international journal of obstetrics and gynaecology

September 1, 2013

p Preeclampsia

c Economics Model
Are there financial savings associated with supplementing current diagnostic practice for preeclampsia with a novel test? Learnings from a modeling analysis from a German payer perspective.

b

Hypertension in pregnancy

May 1, 2013

p Preeclampsia

c Economics Model
Gene-guided gefitinib switch maintenance therapy for patients with advanced EGFR mutation-positive non-small cell lung cancer: an economic analysis.

b

BMC cancer

January 29, 2013

p Cancer

c Economics Model